Entering text into the input field will update the search result below

PMV Pharmaceuticals GAAP EPS of -$1.28 misses by $0.05

Mar. 01, 2022 7:51 AM ETPMV Pharmaceuticals, Inc. (PMVP)By: Deepa Sarvaiya, SA News Editor
  • PMV Pharmaceuticals press release (NASDAQ:PMVP): FY GAAP EPS of -$1.28 misses by $0.05.
  •  Cash, cash equivalents, and marketable securities as of December 31, 2021 of $314.4M  compared to $361.4 million as of December 31, 2020.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.